Cargando…
Prevention of host-to-host transmission by SARS-CoV-2 vaccines
As the number of individuals vaccinated against SARS-CoV-2 rises worldwide, population-level data regarding the vaccines' ability to reduce infection are being generated. Randomised trials have shown that these vaccines dramatically reduce symptomatic COVID-19; however, less is known about thei...
Autores principales: | Mostaghimi, Darius, Valdez, Caroline N, Larson, Haleigh T, Kalinich, Chaney C, Iwasaki, Akiko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8439617/ https://www.ncbi.nlm.nih.gov/pubmed/34534512 http://dx.doi.org/10.1016/S1473-3099(21)00472-2 |
Ejemplares similares
-
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
por: Petersen, Eskild, et al.
Publicado: (2020) -
Perfect as the enemy of good: tracing transmissions with low-sensitivity tests to mitigate SARS-CoV-2 outbreaks
por: Kennedy-Shaffer, Lee, et al.
Publicado: (2021) -
Does infection with or vaccination against SARS-CoV-2 lead to lasting immunity?
por: Milne, Gregory, et al.
Publicado: (2021) -
The bullwhip effect, T-cell telomeres, and SARS-CoV-2
por: Aviv, Abraham
Publicado: (2022) -
Towards an accurate and systematic characterisation of persistently asymptomatic infection with SARS-CoV-2
por: Meyerowitz, Eric A, et al.
Publicado: (2021)